CAS: 1313706-14-7 - Pinatuzumab vedotin
Formula:Unspecified
- Sinonimi:
- FCU 2703
- Immunoglobulin G1, anti-(human antigen CD22) (human-Mus musculus monoclonal MCDT2219A heavy chain), disulfide with human-Mus musculus monoclonal MCDT2219A κ-chain, dimer, thioether with maleimidocaproyl-valine-citrulline-p-aminobenzyloxycarbonyl monomethylauristatin E
- RO 5541072-000
- Immunoglobulin G1, anti-(human sialic acid-binding immunoglobulin-like lectin 2) (human-Mus musculus monoclonal MCDT2219A heavy chain), disulfide with human-Mus musculus monoclonal MCDT2219A κ-chain, dimer, thioether with N-[[[4-[[N-[6-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-L-ornithyl]amino]phenyl]methoxy]carbonyl]-N-methyl-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide
- Pinatuzumab vedotin
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | Pinatuzumab vedotin REF: TM-T9901A-029CAS: 1313706-14-7 | - - - | Prezzo su richiesta | Mar 15 Ott 24 |
 | Pinatuzumab REF: 3D-CLA1324CAS: 1313706-14-7 | - - - | Prezzo su richiesta | Mer 23 Ott 24 |
Ref: TM-T9901A-029
| 1mg | Prezzo su richiesta | ||
| 5mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Martedì 15 Ottobre 2024
Ref: 3D-CLA1324
| Dimensione non definita | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Mercoledì 23 Ottobre 2024
